Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoFuse in posterolateral lumbar fusion
NCT00810212Phase 2Withdrawn
- Sponsor
- Mesoblast Ltd
- Start
- Nov 2008
- Primary completion
- Nov 2011
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of rexlemestrocel-l in degenerative disc disease (DDD), degenerative spondylolisthesis (DS), spinal stenosis, sponsored by Mesoblast Ltd. Planned start Nov 2008; status: withdrawn.
02
Drugs
rexlemestrocel-l
03
Conditions
degenerative disc disease (DDD)degenerative spondylolisthesis (DS)spinal stenosis
Beyond the preview
Go deeper on NCT00810212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810212.